Dermatology

>

Latest News

Reaction to tapinarof cream, 1% sNDA submission with Lawrence Eichenfield, MD
Reaction to tapinarof cream, 1% sNDA submission with Lawrence Eichenfield, MD

February 15th 2024

Lawrence Eichenfield, MD, highlights the sNDA submission of tapinarof cream, 1% for the topical treatment of atopic dermatitis in children aged 2 years and older.

Tapinarof cream, 1% sNDA filed to treat atopic dermatitis in patients 2 years and up | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
Dermavant submits sNDA for tapinarof cream, 1% to treat AD in patients 2 years and up

February 14th 2024

Four-year-old with itchy, red, painful hands following snow exposure
Four-year-old with itchy, red, painful hands following snow exposure

February 8th 2024

 Image Credit: © 523115907 - © 523115907 - stock.adobe.com.
Clinician poll: Can you diagnose this child with itchy, red, and painful hands?

February 6th 2024

Weily Soong, MD | Author provided
A discussion of FDA-approved tralokinumab-ldrm for atopic dermatitis

January 26th 2024

Latest CME Events & Activities

FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates

View More

Earn CME Credits While Advancing Your Expertise in Internal Medicine

April 18-19, 2024

Register Now!

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

3rd Annual International Congress on Pediatric Oncology

October 25, 2024

View More

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Advances In™ Rare Genetic Forms of Obesity: Emerging Therapeutic Targets

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

Comprehensive Approaches to Creating Successful Sickle Cell Management Plans Across Patients’ Lifespans

View More

Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

View More

Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today

View More

Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News

© 2024 MJH Life Sciences

All rights reserved.